Global Chronic Low Back Pain Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1154

Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic.
In 2018, the global Chronic Low Back Pain Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Chronic Low Back Pain Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Low Back Pain Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Johnson & Johnson
Novartis
Takeda Pharmaceutical
Allergan
Teva Pharmaceuticals
Mylan
Stayble Therapeutics
Mesoblast
Axsome Therapeutics

Market segment by Type, the product can be split into
Surgery
Medication

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Chronic Low Back Pain Treatment status, future forecast, growth opportunity, key market and key players.
To present the Chronic Low Back Pain Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Low Back Pain Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Low Back Pain Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Surgery
1.4.3 Medication
1.5 Market by Application
1.5.1 Global Chronic Low Back Pain Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Chronic Low Back Pain Treatment Market Size
2.2 Chronic Low Back Pain Treatment Growth Trends by Regions
2.2.1 Chronic Low Back Pain Treatment Market Size by Regions (2014-2025)
2.2.2 Chronic Low Back Pain Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Chronic Low Back Pain Treatment Market Size by Manufacturers
3.1.1 Global Chronic Low Back Pain Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Chronic Low Back Pain Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chronic Low Back Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Low Back Pain Treatment Key Players Head office and Area Served
3.3 Key Players Chronic Low Back Pain Treatment Product/Solution/Service
3.4 Date of Enter into Chronic Low Back Pain Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Chronic Low Back Pain Treatment Market Size by Type (2014-2019)
4.2 Global Chronic Low Back Pain Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Chronic Low Back Pain Treatment Market Size (2014-2019)
5.2 Chronic Low Back Pain Treatment Key Players in United States
5.3 United States Chronic Low Back Pain Treatment Market Size by Type
5.4 United States Chronic Low Back Pain Treatment Market Size by Application

6 Europe
6.1 Europe Chronic Low Back Pain Treatment Market Size (2014-2019)
6.2 Chronic Low Back Pain Treatment Key Players in Europe
6.3 Europe Chronic Low Back Pain Treatment Market Size by Type
6.4 Europe Chronic Low Back Pain Treatment Market Size by Application

7 China
7.1 China Chronic Low Back Pain Treatment Market Size (2014-2019)
7.2 Chronic Low Back Pain Treatment Key Players in China
7.3 China Chronic Low Back Pain Treatment Market Size by Type
7.4 China Chronic Low Back Pain Treatment Market Size by Application

8 Japan
8.1 Japan Chronic Low Back Pain Treatment Market Size (2014-2019)
8.2 Chronic Low Back Pain Treatment Key Players in Japan
8.3 Japan Chronic Low Back Pain Treatment Market Size by Type
8.4 Japan Chronic Low Back Pain Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Chronic Low Back Pain Treatment Market Size (2014-2019)
9.2 Chronic Low Back Pain Treatment Key Players in Southeast Asia
9.3 Southeast Asia Chronic Low Back Pain Treatment Market Size by Type
9.4 Southeast Asia Chronic Low Back Pain Treatment Market Size by Application

10 India
10.1 India Chronic Low Back Pain Treatment Market Size (2014-2019)
10.2 Chronic Low Back Pain Treatment Key Players in India
10.3 India Chronic Low Back Pain Treatment Market Size by Type
10.4 India Chronic Low Back Pain Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Chronic Low Back Pain Treatment Market Size (2014-2019)
11.2 Chronic Low Back Pain Treatment Key Players in Central & South America
11.3 Central & South America Chronic Low Back Pain Treatment Market Size by Type
11.4 Central & South America Chronic Low Back Pain Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Low Back Pain Treatment Introduction
12.1.4 Pfizer Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Low Back Pain Treatment Introduction
12.2.4 Johnson & Johnson Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Low Back Pain Treatment Introduction
12.3.4 Novartis Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Takeda Pharmaceutical
12.4.1 Takeda Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Low Back Pain Treatment Introduction
12.4.4 Takeda Pharmaceutical Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.4.5 Takeda Pharmaceutical Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Low Back Pain Treatment Introduction
12.5.4 Allergan Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Low Back Pain Treatment Introduction
12.6.4 Teva Pharmaceuticals Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.6.5 Teva Pharmaceuticals Recent Development
12.7 Mylan
12.7.1 Mylan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Low Back Pain Treatment Introduction
12.7.4 Mylan Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.7.5 Mylan Recent Development
12.8 Stayble Therapeutics
12.8.1 Stayble Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Low Back Pain Treatment Introduction
12.8.4 Stayble Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.8.5 Stayble Therapeutics Recent Development
12.9 Mesoblast
12.9.1 Mesoblast Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Low Back Pain Treatment Introduction
12.9.4 Mesoblast Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.9.5 Mesoblast Recent Development
12.10 Axsome Therapeutics
12.10.1 Axsome Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Chronic Low Back Pain Treatment Introduction
12.10.4 Axsome Therapeutics Revenue in Chronic Low Back Pain Treatment Business (2014-2019)
12.10.5 Axsome Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details